Research Report: Society Pass (SOPA) $0.22. Price Target $4.00.
Three New Reports on Society Pass (SOPA) With Price Targets from $3.00 to $4.00.
(All Report Archive)
LQR House (LQR) Commits to Postpone Public Offerings for the Foreseeable Future.
LQR House Initiates Warrants Cancellation and Commits to Postpone Public Offerings for the Foreseeable Future
Continued Strength at LQR House (LQR) Post-Reverse Split.
Like a Surprise Christmas Gift, LQR House has Gained Nearly Four-Fold (330%) Post Split. New Report out Tomorrow.
LQR House (LQR) +65%, Rebounding On New Clients Announcements.
The Liquor House Continues to Impress.
We called this the most interesting Company of 2023. While extreme volume...
Selling Under Cash. LQR House (LQR) Addresses Nasdaq Delisting.
If You're a Sophisticated Speculator, and we do Mean Sophisticated, Study LQR House (LQR) or 'the Liquor House' Story.
LQR Announces Proposed Reverse Split as Part of Nasdaq Compliance Plan
LIVE QUOTE
MIAMI BEACH, FL / ACCESSWIRE / November 21, 2023 / LQR House Inc....
Full Report: Sekur Private Data (SWISF) $0.07.
Our Top Ranked Cybersecurity Speculation
A Growing Number of Users are Saying that Sekur’s Privacy and Safety...
Report: Sekur Private Data (SWISF) $0.06.
Swiss Privacy and Cyber-Security Company Takes Aim at WhatsApp's 2 Billion Users and Proton Mail’s 70 Million Users
Jose Manuel Calderon Joins Hapbee (HAPB).
Prominent athlete participates in Private Placement and will contribute to Hapbee's expansion in global sports.
Thumzup Media (TZUP) Ascends to Top 6.3% of All Active Reg A+ and Reg...
$1 Million Get's You in Top 10% of all Reg A's and Reg CF's?
LIVE QUOTE
Latest article
Nine Page Summary Report on GeoVax (GOVX)
This is a great long-term story. We’re telling you.
(March 2024) When we finished writing our earlier...
GeoVax (GOVX) Provides First Half 2024 Business Update.
Award of BARDA Project NextGen contract represents a significant milestone event;
Total value...
Reverse Split Mania! Solgenix (SNGX) Jumps 448% After 1:16.
Can You Imagine Selling Solgenix at $2.00 yesterday.
And to be honest, news wasn't all that big - such...
